ATLAS / Macro Radar / Reporting / REGN

REGENERON PHARMACEUTICALS, INC. (REGN) reporting calendar

REGENERON PHARMACEUTICALS, INC. files periodic reports with the SEC as REGN on Nasdaq. Atlas tracks 38 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 5 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
29 Apr 2026
Reports on record
38

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 31 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open REGN market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202629 Apr 202629 days0000872589-26-000016
10-K31 Dec 20254 Feb 202635 days0000872589-26-000008
10-Q30 Sep 202528 Oct 202528 days0000872589-25-000028
10-Q30 Jun 20251 Aug 202532 days0000872589-25-000019
10-Q31 Mar 202529 Apr 202529 days0001804220-25-000022
10-K31 Dec 20245 Feb 202536 days0001804220-25-000011
10-Q30 Sep 202431 Oct 202431 days0001804220-24-000040
10-Q30 Jun 20241 Aug 202432 days0001804220-24-000028
10-Q31 Mar 20242 May 202432 days0001804220-24-000017
10-K31 Dec 20235 Feb 202436 days0001804220-24-000009
10-Q30 Sep 20232 Nov 202333 days0001804220-23-000031
10-Q30 Jun 20233 Aug 202334 days0001804220-23-000023
10-Q31 Mar 20234 May 202334 days0001804220-23-000016
10-K31 Dec 20226 Feb 202337 days0001804220-23-000008
10-Q30 Sep 20223 Nov 202234 days0001804220-22-000031
10-Q30 Jun 20223 Aug 202234 days0001804220-22-000023
10-Q31 Mar 20224 May 202234 days0001804220-22-000015
10-K31 Dec 20217 Feb 202238 days0001804220-22-000007
10-Q30 Sep 20214 Nov 202135 days0001804220-21-000033
10-Q30 Jun 20215 Aug 202136 days0001804220-21-000025
10-Q31 Mar 20216 May 202136 days0001804220-21-000017
10-K31 Dec 20208 Feb 202139 days0001804220-21-000008
10-Q30 Sep 20205 Nov 202036 days0001804220-20-000030
10-Q30 Jun 20205 Aug 202036 days0001804220-20-000022
10-Q31 Mar 20205 May 202035 days0001804220-20-000011
10-K31 Dec 20197 Feb 202038 days0001532176-20-000008
10-Q30 Sep 20195 Nov 201936 days0001532176-19-000034
10-Q30 Jun 20196 Aug 201937 days0001532176-19-000026
10-Q31 Mar 20197 May 201937 days0001532176-19-000017
10-K31 Dec 20187 Feb 201938 days0001532176-19-000009
10-Q30 Sep 20186 Nov 201837 days0001532176-18-000036
10-Q30 Jun 20182 Aug 201833 days0001532176-18-000028
10-Q31 Mar 20183 May 201833 days0001532176-18-000020
10-K31 Dec 20178 Feb 201839 days0001532176-18-000013
10-Q30 Sep 20178 Nov 201739 days0001532176-17-000034
10-Q30 Jun 20173 Aug 201734 days0001532176-17-000027
10-Q31 Mar 20174 May 201734 days0001532176-17-000017
10-K31 Dec 20169 Feb 201740 days0001532176-17-000008

Source: SEC EDGAR company submissions for CIK 0000872589. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.